All to know about DIGIPHARM!!!!

Digipharm aims to be the pioneer of sustainable and value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry. We invite you to be a part of this meaningful journey.

Digipharms solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient. In healthcare today, there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximisation of patient outcomes.

Our Vision

To be the pioneer of sustainable and value-based healthcare delivery,
innovative evidence generation and patient empowerment across the healthcare industry.

The Problem

Inherent flaws and infrastructural limitations of the global healthcare systems result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient.

Innovative pricing models provide viable solutions to the aforementioned problems. Unfortunately, most healthcare providers or payers around the world lack the relevant infrastructure to track and implement outcomes based pricing agreements, and so are shy in adopting innovative pricing contracts and policies. In healthcare today, there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximization of patient outcomes. Though it is widely agreed that the transition to value based pricing is necessary, progress in doing so has been slow.

In addition to the barriers in implementing outcome based pricing, patient data is fragmented. The lack of easily accessible and comprehensive real world evidence (RWE) data currently prevents stakeholders in healthcare to evaluate the real time performance and value provided by therapy in real life clinical practice as part of a value based healthcare delivery system.

The SOLUTIONS

Reimburse will eliminate the infrastructural barriers and automate the implementation of value based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalised reimbursement of health technology on a fee for performance basis for the mutual benefit of patients, payers and manufacturers.

Insights is the first ever live real world evidence repository and allows the utilisation of real world evidence (RWE) as soon as it becomes available. The availability of live RWE will provide stakeholders with real time intelligence with which they can inform decision making and product development across the medicinal lifecycle.

Our GOALS

To remove infrastructural barriers and automate the implementation of innovative value-based pricing agreements on a fully independent platform; in order to facilitate personalised reimbursement of health technology on a â€˜fee for performanceâ€™ basis for the mutual benefit of patients, payers and manufacturers.

To develop the worlds first live RWE platform. Allowing the utilisation of real world data (RWD) as soon as it becomes available, to inform health related research, decision making and to incentivise patients to contribute their data.

Value Based Care

Healthcare systems around the world are currently threatened by challenges unique to our time; unsustainable expenditure, aging populations and the increasing prevalence of chronic diseases. The concept of value based healthcare proposes that payment for healthcare should be tied to the quality of care and the benefits it provides; switching from a fee for service to a fee for performance reimbursement model.

Innovative Pricing

Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty around the cost of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivise innovation and encourage the transition to patient centric healthcare.

Pioneering Evidence Generation

Innovative evidence generation solutions are necessary to satisfy the requirement of relevant, timely and data to inform the provision of optimised value based healthcare. Circumventing the use of static or retrospective data will open the horizon to forecasting, confidence in decision making and global oversight with regards to current developments in an increasingly dynamic industry such as healthcare.

The Platform

The Reimburse platform will empower payers and manufacturers to negotiate meticulous pricing agreements, ranging from truly personalised schemes based on surrogate outcomes to wider access agreements applicable to patient cohorts of interest. As the healthcare industry shifts towards patient centric healthcare provision, Reimburse allows patients to be followed, and aggregates data related to patient treatment and outcomes across numerous sites. Use of the Reimburse platform will expedite integration, coordination and delivery of patient centric healthcare systems with a focus on improving patient outcomes while accelerating a˜payment for value mechanisms between payers and manufacturers using neutrally-enforceable agreements in a peer to peer fashion.

Insights will provide a symbiotic solution with Reimburse to complement the progressive transformation towards value based healthcare delivery systems. The development of a a live evidence repository will allow the integration of knowledge back in to the delivery system in real time to facilitate drug development, health related research and post marketing studies.

THE BENEFITS

Private blockchain security for healthcare services

Using a public blockchain is insufficient for what Digipharm wants to offer to its users. Public blockchains (in comparison to private â€˜permissionedâ€™ alternatives) inherently lack privacy and confidentiality functions which are critical when it comes to sensitive patient data and commercial pricing agreements between various parties.

Digipharm Tokens Details

Digipharm (DPH) tokens will be used to pay license/access fees on Digipharm platforms. Access fees will invariably be determined and stipulated in USD value and the quantity of tokens required will depend on the type of access (manufacturer, patient, payer or provider) combined with the form of interaction required. The quantity of tokens required for such interactions is subject to change, relative to the market value of DPH.

Digipharm will enable the restructure of healthcare by merging industry expertise and next generation technology. Our success will be measured by improving patient outcomes, reducing costs, and a strong DPH token utility.